https://www.selleckchem.com/pr....oducts/a-438079-hcl.
A total of 56 patients (15%) died within 2 years. Kaplan-Meier curve analysis demonstrated a 2-year survival of 81% in Group 1, 89% in Group 2, 87% in Group 3, 47% in Group 4, 87% in Group 5, and 79 % in Group 6 (log-rank test, p 0.001). The multivariable Cox proportional-hazards model showed that classification in Group 4 was an independent predictor of mortality (hazard ratio, 4.31; 95% CI 2.19-8.46; p 0.001). The coexistence of significant FMR and PeAF may represent a poor prognostic marker in patients undergoing LVAD
Like
Comment
Share
